2019冠状病毒病与糖尿病：一种共同的“阴谋”？ - Suppr

Suppr

超能文献

COVID-19 and diabetes: a co-conspiracy?

出版信息

Lancet Diabetes Endocrinol. 2020 Oct;8(10):801. doi: 10.1016/S2213-8587(20)30315-6.

DOI:10.1016/S2213-8587(20)30315-6

PMID:32946812

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7492001/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a20/7492001/7c1107482c73/fx1_lrg.jpg

相似文献

COVID-19 and diabetes: a co-conspiracy?

Lancet Diabetes Endocrinol. 2020 Oct;8(10):801. doi: 10.1016/S2213-8587(20)30315-6.

Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis.

Diabetes Care. 2020 Oct;43(10):2336-2338. doi: 10.2337/dci20-0045. Epub 2020 Aug 4.

Prioritising action on diabetes during COVID-19.

S Afr Med J. 2020 Jun 25;110(8):719-720.

Management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Aug;8(8):666-667. doi: 10.1016/S2213-8587(20)30231-X.

Management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Aug;8(8):666. doi: 10.1016/S2213-8587(20)30226-6.

Management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Aug;8(8):667-668. doi: 10.1016/S2213-8587(20)30227-8.

Management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Aug;8(8):668. doi: 10.1016/S2213-8587(20)30234-5.

Management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Aug;8(8):669. doi: 10.1016/S2213-8587(20)30235-7.

"Does having diabetes increase chances of contracting COVID-19 infection?".

Diabetes Metab Syndr. 2020 Sep-Oct;14(5):765-766. doi: 10.1016/j.dsx.2020.05.048. Epub 2020 Jun 1.

COVID-19 and steroid therapy: Impact on diabetes.

Prim Care Diabetes. 2020 Oct;14(5):568. doi: 10.1016/j.pcd.2020.07.013. Epub 2020 Jul 30.

引用本文的文献

Combining bioinformatics and machine learning algorithms to identify and analyze shared biomarkers and pathways in COVID-19 convalescence and diabetes mellitus.

Front Endocrinol (Lausanne). 2023 Dec 19;14:1306325. doi: 10.3389/fendo.2023.1306325. eCollection 2023.

Assessing the Impact of Primary Care-Led Optimisation Clinics in the Management of Type 2 Diabetes: A Service Redesign Pilot Study.

Cureus. 2023 Oct 20;15(10):e47365. doi: 10.7759/cureus.47365. eCollection 2023 Oct.

Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19- Related Severity and Mortality: A Systematic Review and Meta-analysis.

Diabetes Care. 2023 Apr 1;46(4):890-897. doi: 10.2337/dc22-1943.

Time-varying association of acute and post-acute COVID-19 with new-onset diabetes mellitus among hospitalized and non-hospitalized patients.

BMJ Open Diabetes Res Care. 2023 Jan;11(1). doi: 10.1136/bmjdrc-2022-003052.

COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management.

Cureus. 2022 Nov 25;14(11):e31895. doi: 10.7759/cureus.31895. eCollection 2022 Nov.

New Onset of Diabetes Mellitus and Associated Factors among COVID-19 Patients in COVID-19 Care Centers, Addis Ababa, Ethiopia 2022.

J Diabetes Res. 2022 Nov 12;2022:9652940. doi: 10.1155/2022/9652940. eCollection 2022.

An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection.

Comput Biol Med. 2022 Dec;151(Pt A):106050. doi: 10.1016/j.compbiomed.2022.106050. Epub 2022 Aug 25.

Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity.

Diagnostics (Basel). 2022 Oct 17;12(10):2521. doi: 10.3390/diagnostics12102521.

Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis.

PLoS One. 2022 Jul 6;17(7):e0268396. doi: 10.1371/journal.pone.0268396. eCollection 2022.

The evaluation of pancreas β-cell autoantibodies in non-diabetic COVID-19 patients.

Arch Endocrinol Metab. 2022;66(4):459-465. doi: 10.20945/2359-3997000000498. Epub 2022 Jun 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

COVID-19 and diabetes: a co-conspiracy?

Lancet Diabetes Endocrinol. 2020 Oct;8(10):801. doi: 10.1016/S2213-8587(20)30315-6.

Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis.

Diabetes Care. 2020 Oct;43(10):2336-2338. doi: 10.2337/dci20-0045. Epub 2020 Aug 4.

Prioritising action on diabetes during COVID-19.

S Afr Med J. 2020 Jun 25;110(8):719-720.

Management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Aug;8(8):666-667. doi: 10.1016/S2213-8587(20)30231-X.

Management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Aug;8(8):666. doi: 10.1016/S2213-8587(20)30226-6.

Management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Aug;8(8):667-668. doi: 10.1016/S2213-8587(20)30227-8.

Management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Aug;8(8):668. doi: 10.1016/S2213-8587(20)30234-5.

Management of diabetes in patients with COVID-19.

Lancet Diabetes Endocrinol. 2020 Aug;8(8):669. doi: 10.1016/S2213-8587(20)30235-7.

"Does having diabetes increase chances of contracting COVID-19 infection?".

Diabetes Metab Syndr. 2020 Sep-Oct;14(5):765-766. doi: 10.1016/j.dsx.2020.05.048. Epub 2020 Jun 1.

COVID-19 and steroid therapy: Impact on diabetes.

Prim Care Diabetes. 2020 Oct;14(5):568. doi: 10.1016/j.pcd.2020.07.013. Epub 2020 Jul 30.

引用本文的文献

Combining bioinformatics and machine learning algorithms to identify and analyze shared biomarkers and pathways in COVID-19 convalescence and diabetes mellitus.

Front Endocrinol (Lausanne). 2023 Dec 19;14:1306325. doi: 10.3389/fendo.2023.1306325. eCollection 2023.

Assessing the Impact of Primary Care-Led Optimisation Clinics in the Management of Type 2 Diabetes: A Service Redesign Pilot Study.

Cureus. 2023 Oct 20;15(10):e47365. doi: 10.7759/cureus.47365. eCollection 2023 Oct.

Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19- Related Severity and Mortality: A Systematic Review and Meta-analysis.

Diabetes Care. 2023 Apr 1;46(4):890-897. doi: 10.2337/dc22-1943.

Time-varying association of acute and post-acute COVID-19 with new-onset diabetes mellitus among hospitalized and non-hospitalized patients.

BMJ Open Diabetes Res Care. 2023 Jan;11(1). doi: 10.1136/bmjdrc-2022-003052.

COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management.

Cureus. 2022 Nov 25;14(11):e31895. doi: 10.7759/cureus.31895. eCollection 2022 Nov.

New Onset of Diabetes Mellitus and Associated Factors among COVID-19 Patients in COVID-19 Care Centers, Addis Ababa, Ethiopia 2022.

J Diabetes Res. 2022 Nov 12;2022:9652940. doi: 10.1155/2022/9652940. eCollection 2022.

An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection.

Comput Biol Med. 2022 Dec;151(Pt A):106050. doi: 10.1016/j.compbiomed.2022.106050. Epub 2022 Aug 25.

Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity.

Diagnostics (Basel). 2022 Oct 17;12(10):2521. doi: 10.3390/diagnostics12102521.

Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis.

PLoS One. 2022 Jul 6;17(7):e0268396. doi: 10.1371/journal.pone.0268396. eCollection 2022.

The evaluation of pancreas β-cell autoantibodies in non-diabetic COVID-19 patients.

Arch Endocrinol Metab. 2022;66(4):459-465. doi: 10.20945/2359-3997000000498. Epub 2022 Jun 2.